** NeuroOne Medical Technologies Corp's NMTC.O shares down
~36% to $1.02 premarket after overnight follow-on prices
** Co announces 5.25 mln shares at $1, ~37% discount to last
sale
** Co plans to use net offering proceeds to support
commercial launch of its brain monitoring system with Zimmer
Biomet ZBH.N , support FDA submission for its OneRF ablation
system
** Co has ~17.9 mln shares outstanding as of Jun 30, per
most recent SEC filing, and ~14.7 mln shares of public float,
per Refinitiv data
** Through Mon close, stock up 32.5% YTD including ~51% gain
over the past month
** Benchmark Co acting as sole bookrunner for the offering
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))